Albemarle (ALB) Tops Q3 EPS by 1c; Trims FY15 Outlook

Albemarle (NYSE: ALB) reported Q3 EPS of $0.90, $0.01 better than the analyst estimate of $0.89. Revenue for the quarter came in at $905.1 million versus the consensus estimate of $947.03 million.

Albemarle sees FY2015 EPS of $3.65-$3.80, versus prior guidance of $3.65-$4.05 and the consensus of $3.85.

For earnings history and earnings-related data on Albemarle (ALB) click here.

You May Also Be Interested In

• Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
• Karman Space & Defense acquires Walker Precision Engineering
• Profound Medical names Richard Fabian as president